Alpha Diagnostic International, Inc. (ADI) is a U.S.-based biotechnology company headquartered in San Antonio, Texas. Established in 1984, ADI specializes in developing, manufacturing, and supplying diagnostic and quality control reagents and test kits for both human and animal disease research. Their mission is to promote global health through improved vaccine therapeutics and to mitigate the spread of human and animal diseases.
Core Offerings
ADI provides a diverse range of products and services to support various research applications:
- ELISA Kits: ADI offers a comprehensive selection of ELISA kits for detecting antibodies and antigens related to infectious diseases such as Ebola, MERS, HPV, Meningitis B, and more.
- Vaccine Research Tools: The VacciGel series of ELISA kits are designed to identify and measure vaccine components adsorbed on Alum adjuvants, including vaccines for Hepatitis B, Diphtheria, Tetanus, Pertussis, Rabies, and HCG.
- TruStrip Systems: Innovative products like the TruStrip Sample Transfer System and TruStrip Western Blot Validation and Quantification System facilitate accurate sample handling and protein analysis.
- Antibodies and Proteins: ADI provides a wide array of primary antibodies, recombinant proteins, and biosimilars for various research applications.
- Custom Services: The company offers tailored solutions for custom peptide synthesis, antibody production, and assay development to meet specific research needs.
